Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Change in Cash (2020 - 2025)

Candel Therapeutics' Change in Cash history spans 4 years, with the latest figure at -$7.6 million for Q4 2023.

  • On a quarterly basis, Change in Cash rose 58.77% to -$7.6 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$34.6 million, a 171.9% decrease, with the full-year FY2025 number at $17.2 million, down 74.38% from a year prior.
  • Change in Cash hit -$7.6 million in Q4 2023 for Candel Therapeutics, up from -$8.9 million in the prior quarter.
  • Over the last five years, Change in Cash for CADL hit a ceiling of $64.1 million in Q3 2021 and a floor of -$18.4 million in Q4 2022.
  • Historically, Change in Cash has averaged $1.1 million across 4 years, with a median of -$5.7 million in 2021.
  • Biggest five-year swings in Change in Cash: skyrocketed 2964.06% in 2021 and later tumbled 645.02% in 2023.
  • Tracing CADL's Change in Cash over 4 years: stood at $16.8 million in 2020, then plummeted by 134.19% to -$5.7 million in 2021, then plummeted by 219.73% to -$18.4 million in 2022, then soared by 58.77% to -$7.6 million in 2023.
  • Business Quant data shows Change in Cash for CADL at -$7.6 million in Q4 2023, -$8.9 million in Q3 2023, and -$7.4 million in Q2 2023.